Michael Aaron Kelly insider trades
Open-market stock purchases and sales by Michael Aaron Kelly, Director at Prime Medicine, Inc, from SEC Form 4 filings since Apr 17, 2019.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +118%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 5, 2026 | PRME Prime Medicine, Inc | Bought (not open market) | — |
| Jun 1, 2026 | NEO Neogenomics Inc | Bought (not open market) | — |
| Jun 1, 2026 | NEO Neogenomics Inc | Bought (not open market) | — |
| Jun 1, 2026 | NEO Neogenomics Inc | Bought (not open market) | — |
| May 13, 2026 | BOOM DMC Global Inc | Bought (not open market) | — |
| Apr 27, 2026 | FOLD Amicus Therapeutics, Inc | Sold (not open market) | $1.1M |
| Apr 27, 2026 | FOLD Amicus Therapeutics, Inc | Sold (not open market) | $387K |
| Apr 27, 2026 | FOLD Amicus Therapeutics, Inc | Sold (not open market) | $388K |
| Apr 27, 2026 | FOLD Amicus Therapeutics, Inc | Sold (not open market) | $385K |
| Apr 27, 2026 | FOLD Amicus Therapeutics, Inc | Sold (not open market) | $436K |
| Apr 27, 2026 | FOLD Amicus Therapeutics, Inc | Sold (not open market) | $446K |
Companies traded
- PRME Prime Medicine, Inc: other filings, last Jun 5, 2026
- NEO Neogenomics Inc: 1 buy, last Jun 1, 2026
- BOOM DMC Global Inc: other filings, last May 13, 2026
- FOLD Amicus Therapeutics, Inc: other filings, last Apr 27, 2026
- HOOK HOOKIPA Pharma Inc: other filings, last Jun 30, 2022
- APRE Aprea Therapeutics, Inc: other filings, last Jun 30, 2021
Get free alerts when Michael Aaron Kelly files a new trade →